| Literature DB >> 16615881 |
Abstract
There is much interest in developing stem cells and the cells derived from them as therapies for treating human disease and injury, but many biological, technological and regulatory hurdles have to be overcome before these cell therapies can be brought to commercial fruition.Entities:
Mesh：
Year: 2006 PMID： 16615881 DOI： 10.1016/j.cell.2006.03.024
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582